• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第 25 届 EANM 年会米兰 2012 亮点:核医学和分子影像学的最佳表现。

Highlights of the 25th Anniversary EANM Congress Milan 2012: nuclear medicine and molecular imaging at its best.

机构信息

PET-CT Center Linz, Department of Nuclear Medicine & Endocrinology, St Vincent's Hospital, Seilerstaette 4, 4020 Linz, Austria.

出版信息

Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1438-61. doi: 10.1007/s00259-013-2517-5. Epub 2013 Aug 6.

DOI:10.1007/s00259-013-2517-5
PMID:23917722
Abstract

The European Association of Nuclear Medicine (EANM) celebrated its 25th Anniversary Congress in Milan under the chairmanship of Professor Emilio Bombardieri and the auspices of the Italian Society of Nuclear Medicine. As always, the Congress was a great success: more than 5,530 participants from 88 countries came from Europe and beyond. In spite of limited budgets, industry again made an important contribution: New innovative equipment and tracers demonstrating the latest technology and innovations were presented by 122 companies. This review is a brief summary of the major scientific contributions made in the fields of oncology, multimodality imaging, cardiovascular science, neurology and psychiatry, technological innovation and novel tracers, and in other clinical sciences as well as in radionuclide therapy, which all show promising and great innovations.

摘要

欧洲核医学协会(EANM)在主席 Emilio Bombardieri 教授和意大利核医学学会的主持下,于米兰举行了第 25 届周年大会。和往常一样,大会取得了巨大的成功:来自 88 个国家的 5530 多名与会者来自欧洲和其他地区。尽管预算有限,但工业界再次做出了重要贡献:122 家公司展示了最新技术和创新的新型创新设备和示踪剂。这篇综述简要总结了肿瘤学、多模态成像、心血管科学、神经病学和精神病学、技术创新和新型示踪剂以及其他临床科学以及放射性核素治疗领域的主要科学贡献,这些都显示出了有前景的重大创新。

相似文献

1
Highlights of the 25th Anniversary EANM Congress Milan 2012: nuclear medicine and molecular imaging at its best.第 25 届 EANM 年会米兰 2012 亮点:核医学和分子影像学的最佳表现。
Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1438-61. doi: 10.1007/s00259-013-2517-5. Epub 2013 Aug 6.
2
Highlights of the 30th Annual Congress of the EANM, Vienna 2017: "Yes we can - make nuclear medicine great again".第 30 届欧洲核医学协会年会亮点,维也纳 2017 年:“是的,我们可以——让核医学重现辉煌”。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1781-1794. doi: 10.1007/s00259-018-4029-9. Epub 2018 May 3.
3
Highlights of the EANM Congress Barcelona 2009: increasing our impact in diagnostic imaging.2009 年 EANM 巴塞罗那大会亮点:提高我们在诊断成像中的影响力。
Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):799-820. doi: 10.1007/s00259-009-1374-8. Epub 2010 Mar 3.
4
Highlights of the 26th EANM 2013 congress in Lyon: new horizons and further.2013年第26届欧洲核医学与分子影像学会(EANM)里昂大会亮点:新视野及更多内容
Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):792-805. doi: 10.1007/s00259-013-2665-7. Epub 2014 Jan 28.
5
Highlights of the 32th Annual Congress of the EANM, Barcelona 2019: the nucleolympic games of nuclear medicine-a global competition for excellence.2019年巴塞罗那第32届欧洲核医学协会年会亮点:核医学的核仁奥林匹克运动会——一场追求卓越的全球竞赛。
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1808-1819. doi: 10.1007/s00259-020-04833-8. Epub 2020 May 15.
6
Highlights lecture EANM 2014: "Gimme gimme gimme those nuclear Super Troupers".2014年欧洲核医学与分子影像学会(EANM)讲座亮点:“给我给我给我那些核超级明星” 。
Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):781-802. doi: 10.1007/s00259-014-2986-1. Epub 2015 Feb 17.
7
Highlights lecture EANM 2016: "Embracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine".欧洲核医学协会(EANM)2016年讲座亮点:“拥抱分子成像和多模态成像:核医学迈向个性化医疗的明智之举”
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1559-1574. doi: 10.1007/s00259-017-3704-6. Epub 2017 Jun 8.
8
Highlights of the EANM Congress 2011: Birmingham, UK.2011 年 EANM 大会纪要:英国伯明翰。
Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):354-68. doi: 10.1007/s00259-011-2043-2.
9
Current research in nuclear medicine and molecular imaging in Italy: highlights of the 10th National Congress of the Italian Association of Nuclear Medicine and Molecular Imaging.意大利核医学与分子成像领域的当前研究:意大利核医学与分子成像协会第十届全国大会亮点
Q J Nucl Med Mol Imaging. 2011 Jun;55(3):280-300.
10
Current research in nuclear medicine and molecular imaging: highlights of the 23rd Annual EANM Congress.当前核医学和分子影像学研究:第 23 届 EANM 年会要点。
Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):378-99. doi: 10.1007/s00259-010-1698-4. Epub 2011 Jan 4.

本文引用的文献

1
For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis.对于慢性心力衰竭患者,心肌123I-MIBG闪烁扫描术对何种终点具有最大的预后价值?一项汇总个体患者数据的荟萃分析结果
Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):996-1003. doi: 10.1093/ehjci/jeu044. Epub 2014 Mar 30.
2
Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer.比较全身[11C]胆碱 PET/MR 与 PET/CT 在前列腺癌患者中的应用。
Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1486-99. doi: 10.1007/s00259-013-2467-y. Epub 2013 Jul 2.
3
89Zr-bevacizumab PET imaging in primary breast cancer.
89Zr-贝伐珠单抗 PET 显像用于原发性乳腺癌。
J Nucl Med. 2013 Jul;54(7):1014-8. doi: 10.2967/jnumed.112.117218. Epub 2013 May 7.
4
Radioimmunotherapy with 177Lu-DOTA-rituximab: final results of a phase I/II Study in 31 patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomas.177Lu-DOTA-利妥昔单抗放射性免疫治疗:31 例复发性滤泡性、套细胞和其他惰性 B 细胞淋巴瘤患者的 I/II 期研究的最终结果。
J Nucl Med. 2013 Jul;54(7):1045-52. doi: 10.2967/jnumed.112.115170. Epub 2013 Apr 9.
5
Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.124I PET/CT成像在预测转移性甲状腺癌患者接受131I治疗时的吸收剂量方面的效用。
Q J Nucl Med Mol Imaging. 2012 Dec;56(6):509-14.
6
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study.基于生长抑素的放射性核素治疗[90Y-DOTA]-TOC 在神经内分泌肿瘤中的应用:一项 I 期剂量递增研究的长期结果。
J Transl Med. 2013 Jan 15;11:17. doi: 10.1186/1479-5876-11-17.
7
(18)F-fluoride PET/CT in avascular necrosis of the femoral head.(18)F-氟化物 PET/CT 在股骨头缺血性坏死中的应用。
Clin Nucl Med. 2013 Jun;38(6):e265-6. doi: 10.1097/RLU.0b013e318266d036.
8
[Contribution of time of flight and point spread function modeling to the performance characteristics of the PET/CT Biograph mCT scanner].[飞行时间和点扩散函数建模对PET/CT Biograph mCT扫描仪性能特征的贡献]
Rev Esp Med Nucl Imagen Mol. 2013 Jan;32(1):13-21. doi: 10.1016/j.remn.2012.07.001. Epub 2012 Sep 18.
9
Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.钬-166 放射性栓塞治疗不可切除、化疗耐药的肝转移瘤患者(HEPAR 试验):一项 1 期、剂量递增研究。
Lancet Oncol. 2012 Oct;13(10):1025-34. doi: 10.1016/S1470-2045(12)70334-0. Epub 2012 Aug 22.
10
99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study.99mTc-3PRGD2 用于肺癌整合素受体显像:一项多中心研究。
J Nucl Med. 2012 May;53(5):716-22. doi: 10.2967/jnumed.111.098988. Epub 2012 Apr 12.